NASDAQ: DRUG - Bright Minds Biosciences Inc.

Yield per half year: +3 627.1%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Bright Minds Biosciences Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc., a biotechnology company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. Bright Minds Biosciences Inc.

more details
was founded in 2017 and is headquartered in New York, New York.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-03-22
ISIN CA10919W1086
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета cad
Сайт https://brightmindsbio.com
Цена ао 1.09
Change price per day: -0.7466% (40.18)
Change price per week: +3.18% (38.65)
Change price per month: +1.79% (39.18)
Change price per 3 month: +3 168.85% (1.22)
Change price per half year: +3 627.1% (1.07)
Change price per year: +2 688.81% (1.43)
Change price per 3 year: +1 090.45% (3.35)
Change price per 5 year: 0% (39.88)
Change price per 10 year: 0% (39.88)
Change price per year to date: +7.58% (37.07)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 1.33 9
P/E 0 0
EV/EBITDA -0.2851 0
Total: 3.63

Efficiency

Title Value Grade
ROA, % -107.17 0
ROE, % -111.73 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.01 10
Total: 9.8

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 9148 10
Yield EPS, % 4265.42 10
Total: 8
More

Institutions Volume Share, %
AdvisorShares Investments, LLC 188119 4.24
HRT Financial LP 16845 0.38
Renaissance Technologies, LLC 11996 0.27
Virtu Financial LLC 10399 0.23
UBS Group AG 622 0.01
Royal Bank of Canada 278 0.01
Aspire Private Capital, LLC 100 0
Blackrock Inc. 1 0



Head Job title Payment Year of birth
Mr. Ian McDonald Co-Founder, CEO, President & Director N/A 1989 (36 years)
Mr. Ryan E. S. K. Cheung B.Com., CA, CPA Chief Financial Officer 87.89k 1978 (47 years)
Dr. Jan Torleif Pedersen M.Sc., Ph.D. Chief Science Officer & Director 178.37k 1965 (60 years)
Dr. Emer Leahy M.B.A., Ph.D. Consultant N/A 1967 (58 years)
Dr. Mark A. Smith M.D., Ph.D. Chief Medical Officer 239.88k 1955 (70 years)
Mr. Alex Vasilkevich COO & VP of Corporate Development

Address: United States, New York, 19 Vestry Street - open in Google maps, open in Yandex maps
Website: https://brightmindsbio.com